Your browser doesn't support javascript.
loading
Comprehensive single institute experience with melanoma TIL: Long term clinical results, toxicity profile, and prognostic factors of response.
Besser, Michal J; Itzhaki, Orit; Ben-Betzalel, Guy; Zippel, Douglas B; Zikich, Dragoslav; Kubi, Adva; Brezinger, Karin; Nissani, Abraham; Levi, Michal; Zeltzer, Li-At; Ben-Nun, Alon; Asher, Nethanel; Shimoni, Avichai; Nagler, Arnon; Markel, Gal; Shapira-Frommer, Ronnie; Schachter, Jacob.
Afiliação
  • Besser MJ; Ella Lemelbaum Institute for Immuno Oncology, Sheba Medical Center, Ramat Gan, Israel.
  • Itzhaki O; Department of Clinical Microbiology and Immunology, Sackler School of Medicine, Tel Aviv University, Israel.
  • Ben-Betzalel G; Wohl Institute of Translational Medicine, Sheba Medical Center, Israel.
  • Zippel DB; Ella Lemelbaum Institute for Immuno Oncology, Sheba Medical Center, Ramat Gan, Israel.
  • Zikich D; Ella Lemelbaum Institute for Immuno Oncology, Sheba Medical Center, Ramat Gan, Israel.
  • Kubi A; Department of Surgery C, Sheba Medical Center, Israel.
  • Brezinger K; Department of Surgery, Sackler School of Medicine, Tel Aviv University, Israel.
  • Nissani A; Ella Lemelbaum Institute for Immuno Oncology, Sheba Medical Center, Ramat Gan, Israel.
  • Levi M; Ella Lemelbaum Institute for Immuno Oncology, Sheba Medical Center, Ramat Gan, Israel.
  • Zeltzer LA; Ella Lemelbaum Institute for Immuno Oncology, Sheba Medical Center, Ramat Gan, Israel.
  • Ben-Nun A; Ella Lemelbaum Institute for Immuno Oncology, Sheba Medical Center, Ramat Gan, Israel.
  • Asher N; Ella Lemelbaum Institute for Immuno Oncology, Sheba Medical Center, Ramat Gan, Israel.
  • Shimoni A; Ella Lemelbaum Institute for Immuno Oncology, Sheba Medical Center, Ramat Gan, Israel.
  • Nagler A; Department of Thoracic Surgery, Sheba Medical Center, Israel.
  • Markel G; Ella Lemelbaum Institute for Immuno Oncology, Sheba Medical Center, Ramat Gan, Israel.
  • Shapira-Frommer R; Department of Bone Marrow Transplantation, Sheba Medical Center, Israel.
  • Schachter J; Department of Bone Marrow Transplantation, Sheba Medical Center, Israel.
Mol Carcinog ; 59(7): 736-744, 2020 07.
Article em En | MEDLINE | ID: mdl-32250515
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfócitos do Interstício Tumoral / Melanoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfócitos do Interstício Tumoral / Melanoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article